1. Home
  2. HRTG vs ARVN Comparison

HRTG vs ARVN Comparison

Compare HRTG & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$28.64

Market Cap

898.0M

Sector

Finance

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$12.30

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRTG
ARVN
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.0M
781.0M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
HRTG
ARVN
Price
$28.64
$12.30
Analyst Decision
Strong Buy
Buy
Analyst Count
2
21
Target Price
$33.50
$15.71
AVG Volume (30 Days)
344.0K
694.5K
Earning Date
06-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
214.43
58.84
EPS
6.32
N/A
Revenue
$847,330,000.00
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.89
N/A
P/E Ratio
$4.50
N/A
Revenue Growth
3.71
N/A
52 Week Low
$13.28
$5.90
52 Week High
$31.98
$14.22

Technical Indicators

Market Signals
Indicator
HRTG
ARVN
Relative Strength Index (RSI) 62.12 42.75
Support Level $25.47 $11.07
Resistance Level $29.18 $12.62
Average True Range (ATR) 1.27 0.70
MACD 0.16 -0.13
Stochastic Oscillator 89.40 18.86

Price Performance

Historical Comparison
HRTG
ARVN

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: